The insulin-like growth factor 1 receptor (IGF-1R), a member of the receptor tyrosine kinase family, remains unmutated in cancers (Baserga, 1995) and exhibits high expression in various tumors (Soni et al., 2023), thus establishing itself as one of the most extensively investigated kinase targets. Here, IGF1R is linked to cancer.